Roquefort Therapeutics plc
LSE ROQ.L
Roquefort Therapeutics plc Market Capitalization on January 14, 2025: USD 5.97 M
Roquefort Therapeutics plc Market Capitalization is USD 5.97 M on January 14, 2025, a -55.45% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Roquefort Therapeutics plc 52-week high Market Capitalization is USD 17.64 M on February 27, 2024, which is 195.66% above the current Market Capitalization.
-
Roquefort Therapeutics plc 52-week low Market Capitalization is USD 5.97 M on January 14, 2025, which is 0.00% below the current Market Capitalization.
-
Roquefort Therapeutics plc average Market Capitalization for the last 52 weeks is USD 9.32 M.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
LSE: ROQ.L
| CEO | Mr. Trevor Ajanthan Reginald |
| IPO Date | March 22, 2021 |
| Location | United Kingdom |
| Headquarters | Eccleston Yards |
| Employees | 10 |
| Sector | Health Care |
| Industries | |
Description
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email